(Q37846934)

24 August 2017

1 reference

title

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease (English)

1 reference

amyotrophic lateral sclerosis

24 August 2017

main subject

0 references

0 references

2

Wim Robberecht

1 reference

24 August 2017

Thomas Philips

1

1 reference

24 August 2017

publication date

1 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

10

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

253-263

1 reference

Prevalence and patterns of cognitive impairment in sporadic ALS.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Recent advances in motor neuron disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Exome sequencing reveals VCP mutations as a cause of familial ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Mutations of optineurin in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Transgenic-mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

The chemokine system in diverse forms of macrophage activation and polarization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Microglia in ALS: the good, the bad, and the resting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Astrocytes: biology and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Astrocytes are active players in cerebral innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Immune reactivity in a mouse model of familial ALS correlates with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Local self-renewal can sustain CNS microglia maintenance and function throughout adult life.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Bone marrow-derived cells in the central nervous system of a mouse model of amyotrophic lateral sclerosis are associated with blood vessels and express CX(3)CR1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Spinal cord injury reveals multilineage differentiation of ependymal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Onset and progression in inherited ALS determined by motor neurons and microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Altered immune response to CNS viral infection in mice with a conditional knock-down of macrophage-lineage cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Mechanisms underlying inflammation in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Extracellular mutant SOD1 induces microglial-mediated motoneuron injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

P413L CHGB is not associated with ALS susceptibility or age at onset in a Dutch population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Increased cytotoxic potential of microglia from ALS-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Redox modifier genes in amyotrophic lateral sclerosis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Survival in a transgenic model of FALS is independent of iNOS expression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Minocycline delays disease onset and mortality in a transgenic model of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Design, power, and interpretation of studies in the standard murine model of ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Trial of celecoxib in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Microglial upregulation of progranulin as a marker of motor neuron degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Inducible nitric oxide synthase (iNOS) and nitrotyrosine immunoreactivity in the spinal cords of transgenic mice with a G93A mutant SOD1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients: a follow-up case series study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

A clinical trial of creatine in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970015-1

7 January 2021

10.1016/S1474-4422(11)70015-1

Identifiers

DOI

1 reference

24 August 2017

1 reference